NeOnc Technologies Holdings is trading 12.54% higher at $3.32; no reliable report identifies a new company-specific catalyst for the October 23 move.
- The Abu Dhabi research MoU was announced October 21 and is nonbinding; further research activities are subject to separate agreements and approvals.
- The biotech sector is lower and broad market indexes are mixed, neither clearly explaining the gain; the move’s cause remains unclear.